Publicaciones en las que colabora con BENJAMÍN FERNÁNDEZ GUTIÉRREZ (30)

2018

  1. Direct medical costs and their predictors in the EMAR-II cohort: “Variability in the management of rheumatoid arthritis and spondyloarthritis in Spain”

    Reumatologia Clinica, Vol. 14, Núm. 1, pp. 4-8

2008

  1. Differences between rheumatology attending physicians and training residents in the management of rheumatoid arthritis in Spain

    Scandinavian Journal of Rheumatology, Vol. 37, Núm. 6, pp. 419-426

2007

  1. Adjunctive methotrexate for treatment of giant cell arteritis: An individual patient data meta-analysis

    Arthritis and Rheumatism, Vol. 56, Núm. 8, pp. 2789-2797

  2. Disminución del tiempo hasta el primer tratamiento con fármacos modificadores de la enfermedad en pacientes con artritis reumatoide

    Reumatologia Clinica, Vol. 3, Núm. 6, pp. 245-250

  3. Human parvovirus B19, varicella zoster virus, and human herpesvirus-6 in mesenchymal stem cells of patients with osteoarthritis: analysis with quantitative real-time polymerase chain reaction

    Osteoarthritis and Cartilage, Vol. 15, Núm. 4, pp. 475-478

  4. Musculoskeletal work disability for clinicians: Time course and effectiveness of a specialized intervention program by diagnosis

    Arthritis Care and Research, Vol. 57, Núm. 2, pp. 335-342

  5. Variability in the use of orthopedic surgery in patients with rheumatoid arthritis in Spain

    Journal of Rheumatology, Vol. 34, Núm. 7, pp. 1485-1490

2005

  1. A health system program to reduce work disability related to musculoskeletal disorders

    Annals of Internal Medicine, Vol. 143, Núm. 6

2003

  1. Disparate results in studies of methotrexate plus corticosteroids in the treatment of giant cell arteritis: Comment on the article by Hoffman et al [1]

    Arthritis and Rheumatism

  2. Incidencia y características de la tuberculosis en pacientes con enfermedades reumáticas autoinmunes

    Revista Clinica Espanola, Vol. 203, Núm. 4, pp. 178-182

2001

  1. Combined treatment of giant-cell arteritis with methotrexate and prednisone: A randomized, double-blind, placebo-controlled trial

    Annals of Internal Medicine, Vol. 134, Núm. 2, pp. 106-114

  2. Estudio sobre el Manejo de la Artritis Reumatoide en España (emAR) (I). Características de los centros participantes

    Revista Espanola de Reumatologia, Vol. 28, Núm. 10, pp. 413-419

  3. Mechanisms of CD23 hyperexpression on B cells from patients with rheumatoid arthritis

    Journal of Rheumatology, Vol. 28, Núm. 6, pp. 1222-1228

  4. Methotrexate in giant-cell arteritis [2] (multiple letters)

    Annals of Internal Medicine

2000

  1. Lag time between onset of symptoms and access to rheumatology care and DMARD therapy in a cohort of patients with rheumatoid arthritis

    Journal of Rheumatology, Vol. 27, Núm. 10, pp. 2323-2328

  2. Undiagnosed spondyloarthropathy in patients presenting with anterior uveitis

    Journal of Rheumatology, Vol. 27, Núm. 9, pp. 2198-2202

1999

  1. Functional integrity of the CD28 co-stimulatory pathway in T lymphocytes from elderly subjects

    Age and Ageing, Vol. 28, Núm. 2, pp. 221-227

1998

  1. Defective early T and T-dependent B cell activation in systemic lupus erythematosus

    Lupus, Vol. 7, Núm. 5, pp. 314-322

  2. Eye involvement in the spondyloarthropathies

    Rheumatic Disease Clinics of North America, Vol. 24, Núm. 4, pp. 771-784

1997

  1. Características generales y de derivación de una cohorte de pacientes con artritis reumatoide

    Revista Espanola de Reumatologia, Vol. 24, Núm. 4, pp. 111-116